Deucravacitinib is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).
Deucravacitinib is a potent immunosuppressant that may increase the risk of severe infections and malignancy.
Cravacin is a generic version of Sotyktu which is Deucravacitinib indicated for Plaque Psoriasis.
As a Least Developed Country (LDC), Bangladesh received a special waiver under the WTO’s TRIPS Agreement (Trade-Related Aspects of Intellectual Property Rights) until 2033. This allows Bangladesh to produce generic versions of patented drugs without paying royalties, significantly reducing manufacturing costs.
Cravacin tablets should be taken orally once daily with or without food, following your healthcare provider’s exact instructions.
It works by inhibiting a specific protein (TYK2) involved in the immune response, reducing inflammation and skin cell production.
Always inform your doctor about all medications you are taking to avoid interactions.
The safety of Deucravacitinib during pregnancy is not established; consult your doctor before use if pregnant or planning to become pregnant.
Deucravacitinib is not recommended for use in children under 18 years of age.
If you miss a dose, take it as soon as you remember, but skip the missed dose if it’s close to your next scheduled dose.
No. As a commitment to patient affordability, Everest Pharmaceuticals Ltd. proudly introduces Cravacin. This medication is now accessible to patients worldwide at a more affordable price. Contact us to learn more about availability and purchasing options.
The most common side effects of Cravacin include fever, sweats, or chills, muscle aches, weight loss, cough, shortness of breath, blood in your phlegm (mucus), warm, red, or painful skin or sores on your body different from your psoriasis, diarrhea or stomach pain etc.